JUN 19, 2019 08:10 AM PDT

Antidepressants May Impair Empathy

WRITTEN BY: Nouran Amin

Depression is tagged with strong impairments of social functioning. Until recently, researchers believed that acute depression impairs empathy—a necessary skill needed to understand people and interact with others. However, previous studies on empathy examined patients only on antidepressant treatments. Now, unique insights derived from interdisciplinary collaborations— in a research cluster known as "Multimodal Neuroimaging in Clinical Neurosciences”--sought to shed new light on the relationship between effects of acute depressive episodes and antidepressant treatments on empathy responses. The research revealed that antidepressant treatment may impair empathy in regards to pain perception and not just depression itself.

Researchers examined non-medicated patients with acute depression by testing their empathic responses to the pain of others and then comparing these results to the same patients post three month treatment with antidepressants, primarily selective serotonin reuptake inhibitors.

Findings revealed that patients on treatment had lower levels of empathy and when undergoing functional magnetic resonance imaging, they had reduced brain activation in regions associated with empathy. Results were published in in the scientific journal Translational Psychiatry.

"The lowered emotional impact of negative events in a social context possibly allows patients to recover more easily. Nevertheless, the actual impact of reduced empathy on patients' social behavior remains to be explored,” says first author of the study, Markus Rütgen.

Finally, findings concluded that the reduced empathic responses are not caused by the general dampening of negative emotions.

Learn more about treating depression with antidepressants:

Source: University of Vienna

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 19, 2020
Technology
JAN 19, 2020
New Encapsulation Technology
Research at the University of Waterloo has concluded new encapsulation technology that can offer an inexpensive, and effective method for coating liquid me...
JAN 19, 2020
Drug Discovery & Development
JAN 19, 2020
The Side-Effects to A Common Blood Cancer Drug
In a study published in Scientific Reports, a popular cancer drug, known as ruxolitnib, was found to cause an increased weight gain as well as an increase ...
JAN 19, 2020
Drug Discovery & Development
JAN 19, 2020
New Injection that Treats Peanut Allergy
Peanut allergies affect between 1 and 3% of the US population. Associated with a heightened risk of severe anaphylactic reactions, oral immunotherapy is th...
JAN 19, 2020
Drug Discovery & Development
JAN 19, 2020
Drug To Treat Ulcerative Colitis
Biomedical researchers at the University of California—Riverside, found that the therapeutic drug ‘tofacitinib’ used in treating autoimmu...
JAN 19, 2020
Drug Discovery & Development
JAN 19, 2020
Effective Therapeutic Approved for Migraines
The U.S Food and Drug Administration has now approved a new medication for migraines. The drug is called ‘ubrogepant (Ubrelvy)’ and comes in th...
JAN 19, 2020
Drug Discovery & Development
JAN 19, 2020
Novel Drug for Treating Insomnia
The U.S. Food and Drug Administration (FDA) has approved DAYVIGO™ (lemborexant) in 5 mg and 10 mg for the treatment of insomnia among adult patients ...
Loading Comments...